Test Updates

 

Clinical Labs of Hawaii provides test updates for educational purposes to physicians, specialists, and the general public.

 

Test UpdateDate

RSV by NAAT Test Update

Effective September 15, 2021, Clinical Labs will be transitioning to a new molecular platform for respiratory syncytial virus testing.

2021_09_14

25(OH) Vitamin D (Total) Test Update

Effective September 13, 2021 Clinical Labs of Hawaii will be offering 25(OH) Vitamin D (Total) testing at our CLH Heights laboratory.

2021_09_13

New Urinalysis Platform and Updated Report Format

Clinical Labs of Hawaii will be transitioning to the Sysmex UN-Series, a new, automated urinalysis platform.

2021_06_25

New Flow Cytometry Platform Test Update

Effective June 21, 2021, Clinical Labs of Hawaii will be transitioning to the ten-color BD FACSLyric™ Flow Cytometry System as part of our ongoing commitment to excellence.

2021_06_21

SARS-CoV-2 (COVID-19) Serology/Antibody Test Options

CLH now offers two serological (antibody) assays to support clinical evaluation of patients who may have been previously infected or exposed to SARS-CoV-2.

2021_05_03

Toxigenic Clostridium difficile RT-PCR Test Update

Effective March 1, 2021, Clinical Labs of Hawaii will be performing Clostridium difficile testing on the Xpert® C. difficile/Epi.

2021_04_11

Streptozyme Test Update

Effective 10/31/2020, Clinical Labs will no longer offer the Streptozyme test (STRZ). The manufacturer is no longer producing the test and no replacement has been offered.

2020_11_05

RPR Screen with Reflex to Titer

Effective November 2, 2020, Clinical Labs of Hawaii will be performing reflexive titers on all positive RPR specimens. RPR as a stand-alone test will no longer be available.

2020_10_30

Patient information on the requisition and specimen container MUST MATCH EXACTLY

As required by our accrediting agencies, Clinical Labs of Hawaii requisitions and specimen containers must have a minimum of TWO patient identifiers and MATCH EXACLY.

2020_10_29

SARS-CoV-2 (COVID-19) Nasal Collections for Non-Exposure Patients

On August 3, 2020 Clinical Labs of Hawaii will begin offering nasal (anterior nares) collection of SARS-CoV-2 specimens at select locations.

2020_08_14

SARS-CoV-2 (COVID-19) Testing - Patient Data Collection Requirement

On June 4, 2020, the U.S. Department of Health and Human Services (HHS) published new requirements for patient data collection and reporting for COVID-19 test results. Please review this bulletin for more details.

2020_07_25

SARS-CoV-2 (COVID-19) Molecular Testing - Specimen Types

Please review the Clinical Labs of Hawaii frequently asked questions for answers regarding SARS-CoV-2 (COVID-19) molecular testing specimen types.

2020_07_04

SARS-CoV-2 (COVID-19) Molecular Testing

On May 19, 2020, Clinical Laboratories of Hawaii (CLH) began testing for SARS-CoV-2, the virus that causes COVID-19, using a new high-throughput system, called the Aptima® SARS-CoV-2 Assay conducted on the Hologic Panther instrument.

2020_06_29